News

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...
India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...
India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly ...
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...
With Indias rising burden of diabetes and obesity, GLP-1 drugs may play a growing role in treatment. But the excitement must ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.
A Slimming World consultant has said weight loss drugs will never replace slimming groups. This comes as weight loss injections, such as Ozempic, Wegovy, and Mounjaro, have become increasingly popular ...
The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...
Mounjaro, giving it more options to compete with Novo Nordisk's recently launched Wegovy. Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it was so far available ...